Search results for " Screening"

showing 10 items of 898 documents

Synthesis and cytotoxic activity of a new potential DNA bisintercalator: 1,4-Bis{3-[N-(4-chlorobenzo[g]phthalazin-1-yl)aminopropyl]}piperazine

2010

The synthesis of new 1,4-bisalkylamino (2-4) and 1-alkylamino-4-chloro (5-6) substituted benzo[g]phthalazines is reported. Compounds 2-4 and 6 were prepared both in the free and heteroaromatic ring protonated forms. Bifunctional 6 contains the 1,4-bisaminopropylpiperazine chain as a linker between the two heteroaromatic units, whereas 5 is its monofunctional analogue. The in vitro antitumour activity of the synthesized compounds has been tested against human colon, breast and lung carcinoma cells, and also against human glioblastoma cells. Results obtained show that all of them are active in all cases, but bifunctional 6·2HCl is remarkably effective against the four cell lines tested, exhib…

Models MolecularMolecular modelStereochemistryClinical BiochemistryPharmaceutical ScienceAntineoplastic AgentsNucleic Acid DenaturationBiochemistryChemical synthesisPiperazineschemistry.chemical_compoundCell Line TumorNeoplasmsDiamineDrug DiscoveryHumansBifunctionalPiperazineMolecular BiologyCell ProliferationChemistryOrganic ChemistryDNAIntercalating AgentsPiperazinePhthalazinesMolecular MedicineDrug Screening Assays AntitumorLinkerDNAPhthalazines
researchProduct

In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators

2008

One of the major problems in the fight against cancer is drug-resistance, which, at a molecular level, can be acquired through mutations able to deactivate apoptosis. In particular, proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-xl and Bcl-2, are overexpressed in many tumours. The development of new inhibitors of these proteins as potential anticancer therapeutics represents a new frontier. In this work, we carried out an in-silico screening of compounds from a free database of more than 2 million structures (ZINC database), which allowed us to identify 17 sulfonamide derivatives as new potential inhibitors; thes…

Models MolecularProgrammed cell deathDatabases FactualIn silicobcl-X ProteinAntineoplastic AgentsApoptosisBcl-xLDrug resistanceBiologyCatalysisInorganic ChemistryNeoplasmsmedicineAnimalsHumansPhysical and Theoretical ChemistryOrganic ChemistrySulfonamide (medicine)CancerApoptosis Bcl-2 Bcl-xl Inhibitors Molecular dockingmedicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaMolecular medicineComputer Science ApplicationsCell biologyComputational Theory and MathematicsDrug Resistance NeoplasmApoptosisCancer researchbiology.proteinDrug Screening Assays Antitumormedicine.drugJournal of Molecular Modeling
researchProduct

Identification of potential inhibitors targeting BRAF-V600E mutant melanoma cells.

2020

Models MolecularProto-Oncogene Proteins B-rafProtein ConformationMutantMutation MissenseDermatologyInhibitory Concentration 50Structure-Activity RelationshipCell Line TumormedicineHumansPoint MutationMolecular Targeted TherapyPrecision MedicineMelanomaProtein Kinase InhibitorsDose-Response Relationship Drugbusiness.industryMelanomaDrug Repositioningmedicine.diseaseNeoplasm ProteinsBRAF V600EMolecular Docking SimulationAmino Acid SubstitutionDrug DesignCancer researchIdentification (biology)Drug Screening Assays AntitumorbusinessJournal of the American Academy of Dermatology
researchProduct

Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and m…

2019

Abstract Over the latest years phytochemical consumption has been associated to a decreased risk of both the onset and the development of a number of pathological conditions. In this context indicaxanthin, a betalain pigment from Opuntia ficus-indica fruit, has been the object of sound research. Explored, at first, for its mere antioxidant potential, Indicaxanthin is now regarded as a redox-active compound able to exert significant poly-pharmacological effects against several targets in a number of experimental conditions both in vivo and in vitro. This paper aims to provide an overview on the therapeutical effects of indicaxanthin, ranging from the anti-inflammatory to the neuro-modulatory…

Models MolecularPyridinesOpuntia ficusPhytochemicalsContext (language use)Antioxidant potential01 natural sciencesMiceStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compoundMulti targetCell Line TumorNeoplasmsSettore BIO/10 - BiochimicaBetalainDrug DiscoveryAnimalsHumansCell Proliferation030304 developmental biologyInflammationIndicaxanthin Multi-target compound Poly-pharmacology Antioxidant Antiinflammatory Antitumoral Antiproliferative Neuromodulator Molecular modellingPharmacologyBiological Products0303 health sciencesDose-Response Relationship DrugMolecular StructureTraditional medicine010405 organic chemistryNatural compoundOrganic ChemistryOpuntiaGeneral MedicineAntineoplastic Agents PhytogenicSettore CHIM/08 - Chimica FarmaceuticaBetaxanthins0104 chemical sciencesMice Inbred C57BLNeuroprotective AgentsPhytochemicalchemistryBlood-Brain BarrierFruitDrug Screening Assays AntitumorIndicaxanthinEuropean Journal of Medicinal Chemistry
researchProduct

TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-bas…

2006

Abstract A new set of bond-level molecular descriptors (bond-based linear indices) are used here in QSAR (quantitative structure–activity relationship) studies of tyrosinase inhibitors, for finding functions that discriminate between the tyrosinase inhibitor compounds and inactive ones. A database of 246 compounds was collected for this study; all organic chemicals were reported as tyrosinase inhibitors; they had great structural diversity. This dataset can be considered as a helpful tool, not only for theoretical chemists but also for other researchers in this area. The set used as inactive has 412 drugs with other clinical uses. Twelve LDA-based QSAR models were obtained, the first six us…

Models MolecularQuantitative structure–activity relationshipMolecular modelStereochemistryTyrosinaseClinical BiochemistryPharmaceutical ScienceQuantitative Structure-Activity RelationshipBiochemistryModels BiologicalChemometricsMolecular descriptorDrug DiscoveryComputer SimulationMolecular BiologyVirtual screeningMolecular StructureChemistryMonophenol MonooxygenaseOrganic ChemistryDiscriminant AnalysisLinear discriminant analysisModels ChemicalTopological indexMolecular MedicineBiological systemAgaricalesPeptidesAlgorithmsBioorganicmedicinal chemistry
researchProduct

Non-stochastic quadratic fingerprints and LDA-based QSAR models in hit and lead generation through virtual screening: theoretical and experimental as…

2005

In order to explore the ability of non-stochastic quadratic indices to encode chemical information in antimalarials, four quantitative models for the discrimination of compounds having this property were generated and statistically compared. Accuracies of 90.2% and 83.3% for the training and test sets, respectively, were observed for the best of all the models, which included non-stochastic quadratic fingerprints weighted with Pauling electronegativities. With a comparative purpose and as a second validation experiment, an exercise of virtual screening of 65 already-reported antimalarials was carried out. Finally, 17 new compounds were classified as either active/inactive ones and experimen…

Models MolecularQuantitative structure–activity relationshipStereochemistryDrug Evaluation PreclinicalMolecular ConformationQuantitative Structure-Activity RelationshipMolecular conformationChemometricsAntimalarialsQuadratic equationHeterocyclic CompoundsDrug DiscoveryComputer SimulationPharmacologyVirtual screeningChemistryComputer aidOrganic ChemistryReproducibility of ResultsChloroquineGeneral MedicineLinear discriminant analysisDrug DesignTopological indexHeminCrystallizationBiological systemAlgorithmsEuropean Journal of Medicinal Chemistry
researchProduct

Advances in the molecular modeling and quantitative structure–activity relationship-based design for antihistamines

2013

Nowadays the use of antihistamines (AH) is increasing steadily. These drugs are able to act on a variety of pathological conditions of the organism. A number of computer-aided (in silico) approaches have been developed to discover and develop novel AH drugs. Among these methods stand the ones based on drug-receptor docking, thermodynamics, as well as the quantitative structure-activity relationships (QSAR).This review collates the most recent advances in the use of computer approaches for the search and characterization of novel AH drugs. Within the QSAR methods, particular attention will be paid to those based on molecular topology (MT) because of their demonstrated efficacy in discovering…

Models MolecularQuantitative structure–activity relationshipVirtual screeningMolecular modelDrug discoveryComputer scienceIn silicoHistamine AntagonistsQuantitative Structure-Activity RelationshipNanotechnologyComputational biologyDocking (molecular)Drug DesignExpert opinionDrug DiscoveryAnimalsComputer-Aided DesignHumansMolecular topologyExpert Opinion on Drug Discovery
researchProduct

Design and Synthesis of 4-Substituted Indolo[3,2-e][1,2,3]triazolo[1,5-a]pyrimidine Derivatives with Antitumor Activity

2008

New derivatives of the indolo[3,2- e][1,2,3]triazolo[1,5- a]pyrimidine system, substituted in the 4 position, were designed as novel antitumor agents because of their theoretical capability to form stable complexes with DNA fragments. The calculated free energies of binding were found in the range -12.76 --> -39.68 Kcal/mol. The docking studies revealed a common binding mode with the chromophore intercalated between GC base pairs, whereas the side chain lies along the minor groove. Compounds, selected on the basis of the docking studies and suitably synthesized, showed antiproliferative activity against each type of tumor cell line investigated, generally in the low micromolar range. The mo…

Models MolecularSEQUENCE SPECIFICITYMolecular modelPyrimidineStereochemistryDNA-BINDINGBIOLOGICAL INTERESTStereoisomerismAntineoplastic AgentsPyrimidinonesChemical synthesisHeterocyclic Compounds 4 or More RingsAUTOMATED DOCKINGchemistry.chemical_compoundStructure-Activity RelationshipCell Line TumorDrug DiscoveryStructure–activity relationshipHumansALGORITHMBinding siteCell ProliferationBinding SitesMolecular StructureChemistryBiological activityStereoisomerismDOMINO REACTIONDNADocking (molecular)Drug DesignNATIONAL-CANCER-INSTITUTEACTINOMYCIN-DMolecular MedicineCOMPLEXESDrug Screening Assays AntitumorTUMOR-CELL-LINES
researchProduct

Synthesis and antiproliferative activity of new derivatives containing the polycyclic system 5,7:7,13-dimethanopyrazolo[3,4-b]pyrazolo[3’,4’:2,3]azep…

2013

The reaction under reflux between 1-phenyl-3-R-5-methylaminopyrazoles and 2,5-hexanedione lead to 5,7:7,13-dimethanopyrazolo[3,4-b]pyrazolo[3′,4′:2,3]azepino[4,5-f]azocine derivatives 3b–g. These unusual molecules show the structural complexity of many biologically active natural products and are endowed with the chemical diversity that is required in drug discovery. The compounds 3b,e were reduced by hydrogen in the presence of Palladium on activated charcoal to give the dihydro derivatives 5b,e. Compounds 3b–f and 5b,e were selected by the NCI to evaluate their in vitro antiproliferative activity against 60 human cell lines derived from nine clinically isolated cancer types (leukaemia, lu…

Models MolecularStereochemistryAntineoplastic AgentsHL-60 CellsHeterocyclic Compounds 4 or More RingsDephosphorylationchemistry.chemical_compoundStructure-Activity RelationshipCell Line TumorSettore BIO/10 - BiochimicaDrug DiscoverymedicineMoleculeHumansAzocinePolycyclic CompoundsCell ProliferationPharmacologyDose-Response Relationship DrugMolecular StructureDrug discoveryOrganic ChemistryCell CycleCancerBiological activityGeneral MedicineCell cyclemedicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaIn vitrochemistryMCF-7 Cells57:713-dimethanopyrazolo[34-b]pyrazolo[3’4’:23]azepino[45-f]azocine derivatives antiproliferative activity G0-G1 arrest pRbDrug Screening Assays AntitumorK562 Cells
researchProduct

Application of molecular topology to the prediction of the antimalarial activity of a group of uracil-based acyclic and deoxyuridine compounds.

2008

A topological-mathematical model has been arranged to search for new derivatives of deoxyuridine and related compounds acting as antimalarials against Plasmodium falciparum. By using linear discriminant and multilinear regression analysis a model with two functions was capable to predict adequately the IC(50) for each compound of the training and test series. After carrying out a virtual screening based upon such a model, new structures potentially active against P. falciparum are proposed.

Models MolecularStereochemistryChemistry PharmaceuticalPlasmodium falciparumPharmaceutical ScienceQuantitative Structure-Activity Relationshipchemistry.chemical_compoundAntimalarialsUser-Computer Interfaceparasitic diseasesAnimalsTechnology PharmaceuticalComputer SimulationUracilTopology (chemistry)Virtual screeningbiologyMolecular StructureDiscriminant AnalysisUracilPlasmodium falciparumLinear discriminant analysisbiology.organism_classificationDeoxyuridineDeoxyuridinechemistryDrug DesignComputer-Aided DesignRegression AnalysisMultiple linear regression analysisMolecular topologyInternational journal of pharmaceutics
researchProduct